Phibro Animal Earnings Estimate

PAHC Stock  USD 51.85  1.22  2.30%   
By analyzing Phibro Animal's earnings estimates, investors can diagnose different trends across Phibro Animal's analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for Phibro Animal Health is based on EPS before non-recurring items and includes expenses related to employee stock options.
 
Yuan Drop
 
Covid
 
Interest Hikes
Phibro Animal is projected to generate 0.7131 in earnings per share on the 31st of March 2026. Phibro Animal earnings estimates show analyst consensus about projected Phibro Animal Health EPS (Earning Per Share). It derives the highest and the lowest estimates based on Phibro Animal's historical volatility. Many public companies, such as Phibro Animal, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm. By analyzing Phibro Animal's earnings estimates, investors can diagnose different trends across Phibro Animal's analyst sentiment over time as well as compare current estimates against different timeframes. At present, Phibro Animal's Net Profit Margin is projected to slightly decrease based on the last few years of reporting. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Phibro Animal Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.

Phibro Animal Earnings per Share Projection vs Actual

About Phibro Animal Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Phibro Animal earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Phibro Animal estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Phibro Animal fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.
Last ReportedProjected for Next Year
Retained Earnings313.6 M329.3 M
Retained Earnings Total Equity300 M315.1 M
Earnings Yield 0.04  0.04 
Price Earnings Ratio 19.29  11.78 
Price Earnings To Growth Ratio 0.01  0.01 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Phibro Animal Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Phibro Animal's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Phibro Animal Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Phibro Animal Health Stock:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Phibro Animal Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.
You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Will Pharmaceuticals sector continue expanding? Could Phibro diversify its offerings? Factors like these will boost the valuation of Phibro Animal. Anticipated expansion of Phibro directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Phibro Animal data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth
7.52
Dividend Share
0.48
Earnings Share
2.21
Revenue Per Share
36.129
Quarterly Revenue Growth
0.209
The market value of Phibro Animal Health is measured differently than its book value, which is the value of Phibro that is recorded on the company's balance sheet. Investors also form their own opinion of Phibro Animal's value that differs from its market value or its book value, called intrinsic value, which is Phibro Animal's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Phibro Animal's market value can be influenced by many factors that don't directly affect Phibro Animal's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Phibro Animal's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Phibro Animal should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Phibro Animal's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.